Acromegaly is a chronic disease caused by excessive growth hormone (GH) release from an adenoma originating from the somatotroph cells of the pituitary gland (>95%). The mean age at diagnosis ranges from 40–47 years, with a prevalence of 28–137 per million, with an incidence of 2–11 cases / year. Community studies have shown that the most common finding in acromegalic patients is acral growth (78–85%) and percentage roughening (70%). Headache, macroglossia, increased sweating, arthralgia, skin thickening, snoring, fatigue and carpal tunnel syndrome (CTS) are other common findings. Clinical signs and symptoms are important in these patients with late diagnosis. Since CTS is seen frequently in the community, it is recommended to measure insulin-like growth factor 1 (IGF-1) in these cases. Thus, we think that these patients should be screened for acromegaly. We wanted to explain this situation with a short statement.